Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Educational Intervention for Patients Undergoing Cardiac Surgery (CARDIO-EDU)

6. Juli 2026 aktualisiert von: Anna Farrús Torrella

Effectiveness of a Nursing Intervention for the Preparation and Follow-up of Patients Undergoing Cardiovascular Surgery. Design and Evaluation of a Nursing Educational Program for the Preparation and Follow-up of Patients Undergoing Cardiovascular Surgery.

Cardiovascular surgery is associated with high levels of anxiety, uncertainty, and postoperative complications. Educational interventions led by nurses may improve patients' psychological adaptation, self-care abilities, and recovery outcomes.

This randomized controlled trial aims to evaluate the effectiveness of a nurse-led educational program designed to prepare and support patients undergoing cardiovascular surgery. Participants are randomly assigned to either an intervention group receiving a structured perioperative educational program or a control group receiving usual care.

The primary outcome is anxiety. Secondary outcomes include posoperative complications, patient satisfaction, pain intensity, length of ICU Stay, length of Hospital Stay, Body Mass Index, blood pressure, fasting blood glucose, Glycated Hemoglobin (HbA1c) and total Cholesterol. Participants are followed for six months after surgery.

Studienübersicht

Status

Abgeschlossen

Detaillierte Beschreibung

Patients undergoing cardiovascular surgery frequently experience anxiety and uncertainty before surgery and during postoperative recovery. Adequate preparation and follow-up may improve psychological well-being, promote self-care, and facilitate recovery.

This single-center randomized controlled trial evaluates a nurse-led educational intervention for patients undergoing elective cardiovascular surgery at Hospital Clínic de Barcelona. The intervention includes structured education and follow-up throughout the perioperative period, focusing on preparation for surgery, postoperative recovery, self-care, symptom management, and lifestyle recommendations.

Participants are randomly allocated to either the intervention group or the usual care group. Outcomes are assessed at baseline, during hospitalization, and during follow-up up to six months after surgery.

The primary outcome is anxiety measured using validated assessment instruments. Secondary outcomes include self-efficacy, self-care capacity, health-related quality of life, postoperative complications, hospital readmissions, healthcare utilization, and patient satisfaction.

The study aims to determine whether a structured nurse-led educational program improves psychological, behavioral, and clinical outcomes in patients undergoing cardiovascular surgery.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

261

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Barcelona
      • Barcelona, Barcelona, Spanien, 08036
        • Hospital Clinic de Barcelona

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Patients undergoing first-time cardiac surgery.
  • Ability to understand and communicate in Spanish or Catalan.
  • Provision of written informed consent.

Exclusion Criteria:

  • Refusal or inability to provide informed consent.
  • Previous cardiovascular surgery.
  • Transcatheter aortic valve implantation (TAVI) or other percutaneous procedures.
  • Cardiogenic shock before surgery requiring sedation and endotracheal intubation.
  • Psychiatric disorders requiring treatment, including anxiety disorders, depression, alcoholism, dementia, psychosis, schizophrenia, amnesia, or personality disorders.
  • Severe chronic diseases, including cirrhosis, hepatitis B or C, HIV/AIDS, Parkinson's disease, severe autoimmune disorders, blindness, or severe hearing impairment.
  • Intensive care unit stay longer than 15 days after surgery.
  • Death during hospitalization, including perioperative mortality.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Kein Eingriff: Kontrollgruppe
Übliche Pflege
Experimental: Experimental Group
Nurse-Led Educational Intervention
A structured nurse-led educational program delivered throughout the perioperative period for patients undergoing cardiovascular surgery. The intervention included preoperative education, preparation for surgery, postoperative recovery guidance, self-care education, symptom management, lifestyle recommendations, and follow-up support after hospital discharge. The program aimed to reduce anxiety and improve self-efficacy, self-care, and recovery outcomes.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Anxiety
Zeitfenster: Baseline through 6 months after surgery
Anxiety assessed using the Hospital Anxiety and Depression Scale (HADS). Total HADS scores range from 0 to 42, with higher scores indicating greater emotional distress.
Baseline through 6 months after surgery

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postoperative Complications
Zeitfenster: From surgery until 6 months post-surgery
Number and type of postoperative complications during hospitalization and within 6 months after cardiovascular surgery, including atrial fibrillation, hypotension, hypertension, acute kidney injury, acute respiratory distress syndrome, surgical wound infection, delirium, and hospital readmission.
From surgery until 6 months post-surgery
Pain Intensity
Zeitfenster: Hospitalization through 6 months post-surgery
Pain assessed using the Numeric Rating Scale (NRS/EVN) during hospitalization and follow-up. Scores range from 0 (no pain) to 10 (worst imaginable pain), with higher scores indicating greater pain intensity.
Hospitalization through 6 months post-surgery
Patient Satisfaction
Zeitfenster: 6 months post-surgery
Patient satisfaction with perioperative education, preparation, support, and follow-up measured using a study-specific questionnaire. Scores range from 0 to 40, with higher scores indicating greater satisfaction.
6 months post-surgery
Length of ICU Stay
Zeitfenster: From ICU admission after surgery until ICU discharge during the index hospitalization (up to 15 days after surgery).
Number of days spent in the intensive care unit after cardiovascular surgery. From ICU admission after surgery until ICU discharge, during the index hospitalization.
From ICU admission after surgery until ICU discharge during the index hospitalization (up to 15 days after surgery).
Length of Hospital Stay
Zeitfenster: From hospital admission until hospital discharge (up to 30 days after surgery)
Total number of days hospitalized following cardiovascular surgery. From hospital admission (previous day of surgery) until hospital discharge.
From hospital admission until hospital discharge (up to 30 days after surgery)
Body Mass Index
Zeitfenster: Baseline, hospital admission, and 6 months post-surgery
Change in body mass index measured before surgery and at follow-up.
Baseline, hospital admission, and 6 months post-surgery
Blood Pressure
Zeitfenster: Baseline, hospital admission, and 6 months post-surgery
Change in blood pressure measured before surgery and at follow-up.
Baseline, hospital admission, and 6 months post-surgery
Fasting Blood Glucose
Zeitfenster: Baseline, hospital admission, and 6 months post-surgery
Change in fasting blood glucose measured before surgery and at follow-up.
Baseline, hospital admission, and 6 months post-surgery
Glycated Hemoglobin (HbA1c)
Zeitfenster: Baseline, hospital admission, and 6 months post-surgery
Change in glycated hemoglobin levels measured before surgery and at follow-up.
Baseline, hospital admission, and 6 months post-surgery
Total Cholesterol
Zeitfenster: Baseline, hospital admission, and 6 months post-surgery
Change in total cholesterol levels measured before surgery and at follow-up.
Baseline, hospital admission, and 6 months post-surgery

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Anna Farrús Torrella, RN, MSc, PhD Candidate, Hospital Clínic de Barcelona/Universitat de Barcelona

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

20. Januar 2024

Primärer Abschluss (Tatsächlich)

2. Februar 2026

Studienabschluss (Tatsächlich)

2. Februar 2026

Studienanmeldedaten

Zuerst eingereicht

17. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

26. Juni 2026

Zuerst gepostet (Tatsächlich)

2. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

8. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

6. Juli 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Nurse-Led Educational Program

3
Abonnieren